Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.90 $1.74 Thursday, 9th May 2024 FGEN stock ended at $1.22. This is 7.96% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 20.73% from a day low at $1.06 to a day high of $1.28.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Mar 01, 2023 $22.32 $22.91 $21.98 $22.04 890 756
Feb 28, 2023 $23.53 $23.53 $21.83 $22.20 2 318 597
Feb 27, 2023 $22.53 $22.71 $22.22 $22.51 606 244
Feb 24, 2023 $22.15 $22.60 $21.80 $22.21 635 014
Feb 23, 2023 $22.62 $22.69 $22.17 $22.44 547 859
Feb 22, 2023 $22.85 $23.00 $22.33 $22.52 629 348
Feb 21, 2023 $23.44 $23.49 $22.57 $22.60 1 128 904
Feb 17, 2023 $23.65 $23.94 $23.16 $23.81 529 537
Feb 16, 2023 $23.92 $24.13 $23.40 $23.58 621 759
Feb 15, 2023 $24.33 $24.65 $24.11 $24.36 457 260
Feb 14, 2023 $24.40 $24.72 $24.18 $24.56 909 194
Feb 13, 2023 $24.27 $24.66 $23.94 $24.55 333 667
Feb 10, 2023 $24.37 $24.45 $23.62 $24.22 545 444
Feb 09, 2023 $24.80 $24.80 $24.10 $24.41 521 343
Feb 08, 2023 $25.18 $25.18 $24.33 $24.48 567 815
Feb 07, 2023 $24.76 $25.31 $24.27 $25.18 626 981
Feb 06, 2023 $24.44 $25.68 $24.27 $24.93 1 047 005
Feb 03, 2023 $24.51 $25.69 $24.43 $24.57 529 197
Feb 02, 2023 $24.58 $24.93 $24.10 $24.85 945 442
Feb 01, 2023 $23.60 $24.58 $23.44 $24.39 1 114 516
Jan 31, 2023 $22.10 $23.79 $22.10 $23.60 1 437 539
Jan 30, 2023 $21.70 $21.89 $21.25 $21.59 937 958
Jan 27, 2023 $22.09 $22.50 $21.64 $21.75 487 816
Jan 26, 2023 $21.89 $22.63 $21.41 $22.11 1 176 812
Jan 25, 2023 $20.19 $20.83 $19.29 $20.65 493 973
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT